Download PDF
Semin Thromb Hemost 2002; 28(4): 355-360
DOI: 10.1055/s-2002-34304
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Effects of Calcium Ions on the Interactions between Antithrombin and Factor Xa Mediated by Variously Sulfated, Semisynthetic Low-Molecular-Weight Heparins

Claudia Sissi1 , Lorena Lucatello1 , Annamaria Naggi2 , Giangiacomo Torri2 , Manlio Palumbo1
  • 1Department of Pharmaceutical Sciences, University of Padova, Padova, Italy
  • 2Istituto Scientifico di Chimica e Biochimica "G.Ronzoni", Milano, Italy
Further Information

Publication History

Publication Date:
23 September 2002 (online)

    Permissions and Reprints

ABSTRACT

A homogeneous set of low-molecular weight heparins, chemically modified to yield different degrees of sulfation, were investigated for their ability to interfere with the antithrombin (AT)-factor Xa (FXa) interaction process in the presence or absence of physiological concentrations of calcium ions. The heparin-AT dissociation constants were not appreciably affected by the presence of the metal ion, whereas the catalytic process was strongly dependent on Ca2+. Our data suggest that AT binding to heparin represents the main factor driving the FXa inhibition process. In addition, the presence of the metal ion is likely to mask favorable AT- heparin ionic contacts occurring with the highly sulfated material. These results help in assessing proper structure-activity relationships for glycosaminoglycans, a multitarget family of biologically active compounds.

KEYWORDS

Heparin - factor Xa - antithrombin - sulfation degree - calcium

REFERENCES

  • 1 Hirsh J. Heparin.  N Engl J Med . 1991;  324 1565-1574
    CrossrefPubMedGoogle Scholar
  • 2 Casu B, Lindahl U. Structure and biological interactions of heparin and heparan sulfate.  Adv Carbohydr Chem Biochem . 2001;  57 159-206
    PubMedGoogle Scholar
  • 3 Kjellen L, Lindahl U. Proteoglycans: structures and interactions.  Annu Rev Biochem . 1991;  60 443-475
    CrossrefPubMedGoogle Scholar
  • 4 Gettings P GW, Patson P A, Olson S T. Serpins: Structure, Function and Biology.  Austin, TX: RG Landes 1996
    Google Scholar
  • 5 Björk I, Olson S T. Antithrombin. A bloody important serpin.  Adv Exp Med Biol . 1997;  425 17-33
    PubMedGoogle Scholar
  • 6 Lin L, Abrahams J P, Skinner R. The anticoagulant activation of antithrombin by heparin.  Proc Natl Acad Sci USA . 1997;  94 14683-14688
    CrossrefPubMedGoogle Scholar
  • 7 Carrell R W, Evans D L, Stein P E. Mobile reactive centre of serpins and the control of thrombosis.  Nature . 1991;  353 576-578
    CrossrefPubMedGoogle Scholar
  • 8 Desai R U, Petitou M, Björk I, Olson S T. Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites.  Biochemistry . 1998;  37 13033-13041
    CrossrefPubMedGoogle Scholar
  • 9 Petitou M, Herault J P, Bernat A. Synthesis of thrombin-inhibiting heparin mimetics without side effects.  Nature . 1999;  398 418-422
    PubMedGoogle Scholar
  • 10 Olson S T, Björk I, Sheffer R. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.  J Biol Chem . 1992;  267 12528-12538
    PubMedGoogle Scholar
  • 11 Olson S T, Björk I. Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction. Elucidation from salt concentration effects.  J Biol Chem . 1991;  266 6353-6364
    PubMedGoogle Scholar
  • 12 Rezaie A R. Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by a template mechanism. Evidence that calcium alleviates Gla domain antagonism of heparin binding to factor Xa.  J Biol Chem . 1998;  273 16824-16827
    CrossrefPubMedGoogle Scholar
  • 13 Lin P, Sinha U, Betz A. Antithrombin binding of low molecular weight heparins and inhibition of factor Xa.  Biochim Biophys Acta . 2001;  1526 105-113
    PubMedGoogle Scholar
  • 14 Sissi C, Naggi A, Torri G, Palumbo M. Effects of sulfation on antithrombin-thrombin/factor Xa interactions in semisynthetic low-molecular-weight heparins.  Semin Thromb Hemost . 2001;  27 483-487
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Naggi A, Torri G, Casu B. ``Supersulfated'' heparin fragments, a new type of low-molecular weight heparin. Physico-chemical and pharmacological properties.  Biochem Pharmacol . 1987;  36 1895-1900
    CrossrefPubMedGoogle Scholar
  • 16 Naggi A, De Cristofano B, Bisio A, Torri G, Casu B. Generation of antifactor Xa active 3Osulfated glucosamine rich sequences by controlled desulfation of oversulfated heparins.  Carbohydr Res . 2001;  336 283-290
    CrossrefPubMedGoogle Scholar
  • 17 Nordenman B, Nystrom C, Björk I. The size and shape of human and bovine antithrombin III.  Eur J Biochem . 1977;  78 195-203
    CrossrefPubMedGoogle Scholar
  • 18 Jesty J, Esnouf M P. The preparation of activated factor X and its action on prothrombin.  Biochem J . 1973;  131 791-799
    PubMedGoogle Scholar
  • 19 Olson S T, Björk I, Shore J D. Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin.  Methods Enzymol . 1993;  22 525-559
    PubMedGoogle Scholar
  • 20 Evans S A, Olson S T, Shore J D. p-Aminobenzamidine as a fluorescent probe for the active site of serine proteases.  J Biol Chem . 1982;  257 3014-3017
    PubMedGoogle Scholar
  • 21 Nordenman B, Björk I. Influence of ionic strength and pH on the interaction between high-affinity heparin and antithrombin.  Biochim Biophys Acta . 1981;  672 227-238
    PubMedGoogle Scholar
  • 22 Einarsson R, Andersson L O. Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence.  Biochim Biophys Acta . 1976;  490 104-111
    PubMedGoogle Scholar
      >